Navigation Links
HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
Date:6/4/2013

FRAMINGHAM, Mass. and SYDNEY, June 4, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Goldman Sachs 34th Annual Global Healthcare Conference at 8:00 a.m. PDT (11:00 am EDT) on Wednesday, June 12, 2013.  The conference is being held June 11-13 at the Terranea Resort in Rancho Palos Verdes, CA.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 30 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
2. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
3. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
4. HeartWare Schedules First Quarter Conference Call And Webcast
5. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
6. HeartWare International, Inc. Announces Public Offering of Common Stock
7. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
8. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
9. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
10. HeartWare Schedules Fourth Quarter Conference Call and Webcast
11. HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... , July 13, 2017 RK Logistics Group, ... of Pharmacy certification for its Fremont, CA ... solutions in the Tri-Valley and San Jose ... City of Fremont , with its Fremont Innovation ... to provide such a powerful resource to the hundreds of ...
(Date:7/12/2017)... INDIANAPOLIS , July 12, 2017  Eli Lilly and ... settlement agreement with generic companies to resolve pending patent litigation ... Virginia regarding the Cialis ® ... expire on April 26, 2020. As part of the agreement, ... on September 27, 2018. "The unit dose patent ...
(Date:7/11/2017)... 2017  The global market for liquid biopsy diagnostic ... million in 2016.  Although in early stages, the global ... particular as a result of the gradual shift towards ... introduction of a significant number of new liquid biopsy ... tumor biomarkers to guide treatment decisions. ...
Breaking Medicine Technology:
(Date:7/26/2017)... WI (PRWEB) , ... July 26, 2017 , ... The ... 2030 in the United States, but ways to improve asthma control in the population ... Clinical Immunology: In Practice (JACI: In Practice), an official journal of the American Academy ...
(Date:7/25/2017)... ... July 25, 2017 , ... Summers in Palm Springs sizzle, but there are ... homemade gourmet ice cream, sparkling pools, and mile-high fun. , At Arrive's Ice Cream ... and other must-have knick knacks. Ice cream and sorbet flavors rotate, but the classics ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... of their partnership to provide the Pharmacist eCare Plan to Computer-Rx ... the country with the ability to develop the Pharmacist eCare Plan, a shared ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... it will be exhibiting and providing demos of its smart journaling platform at ... Convention Center in Washington D.C. from August 3-6, 2017. , The APA Annual ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... in the United States, today announced its partnership with financial technology company, Automated ... The foundation of the solution lies within Hyosung’s superior ATMs, assisted self-service devices ...
Breaking Medicine News(10 mins):